Product Program year 2020 Source: CMS Open Payments

Byl719

Drug

Open in the dashboard

General payments

$45,883

10 payments

Research payments

$0

0 payments

Through program year 2020, $45,883 in general payments and $0 in research payments were reported against Byl719.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $45,883 10

Breakdown

Who paid General payments · program year 2020
  1. Novartis Pharmaceuticals Corporation $45,883 10 payments
Top recipients General payments · program year 2020
  1. Ilona Frieden Pediatrics · San Francisco, CA $10,080 22% · 2 payments
  2. Denise Adams Pediatric Hematology-Oncology · Boston, MA $9,516 21% · 2 payments
  3. Ahmad Alomari Diagnostic Radiology · Boston, MA $9,347 20% · 2 payments
  4. Adrienne Hammill Pediatric Hematology-Oncology · Cincinnati, OH $8,540 19% · 2 payments
  5. Megha Tollefson Dermatology · Rochester, MN $8,400 18% · 2 payments

Each share is of general payments naming this product in 2020.

Specialties paid General payments · program year 2020
  1. Pediatric Hematology-Oncology Pediatrics $18,056 39% · 2 practitioners
  2. Pediatrics $10,080 22% · 1 practitioner
  3. Diagnostic Radiology Radiology $9,347 20% · 1 practitioner
  4. Dermatology $8,400 18% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Massachusetts $18,863 41% · 2 recipients
  2. California $10,080 22% · 1 recipient
  3. Ohio $8,540 19% · 1 recipient
  4. Minnesota $8,400 18% · 1 recipient

Each share is of general payments naming this product in 2020 where a state was reported.

10 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record